Comprehensive Multi-Omics Profiling Reveals GJB2 as a Driver of Spatial Immune Exclusion and a Novel Therapeutic Target in Lung Adenocarcinoma

Published: 17 September 2026| Version 1 | DOI: 10.17632/dygdycdy6b.1
Contributor:
Yusheng Zhang

Description

No

Files

Categories

Lung, Immune Regulation

Licence